Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in RET-altered Non Small Cell Lung Cancer
View Full LandscapeTarget Indication
RET-altered Non Small Cell Lung Cancer
Clinical Trial
NCT03037385Last updated: 2/9/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Chronic Obstructive Pulmonary Disease (COPD)
Non-Small Cell Lung Cancer
Schizophrenia
Squamous Non-Small Cell Lung Cancer
Lupus Nephritis